Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 6;10(7):e0132421.
doi: 10.1371/journal.pone.0132421. eCollection 2015.

The Health-Related Quality of Life for Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)

Affiliations
Free PMC article

The Health-Related Quality of Life for Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)

Michael Falk Hvidberg et al. PLoS One. .
Free PMC article

Abstract

Introduction: Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is a common, severe condition affecting 0.2 to 0.4 per cent of the population. Even so, no recent international EQ-5D based health-related quality of life (HRQoL) estimates exist for ME/CFS patients. The main purpose of this study was to estimate HRQoL scores using the EQ-5D-3L with Danish time trade-off tariffs. Secondary, the aims were to explore whether the results are not influenced by other conditions using regression, to compare the estimates to 20 other conditions and finally to present ME/CFS patient characteristics for use in clinical practice.

Material and methods: All members of the Danish ME/CFS Patient Association in 2013 (n=319) were asked to fill out a questionnaire including the EQ-5D-3L. From these, 105 ME/CFS patients were identified and gave valid responses. Unadjusted EQ-5D-3L means were calculated and compared to the population mean as well as to the mean of 20 other conditions. Furthermore, adjusted estimates were calculated using ordinary least squares (OLS) regression, adjusting for gender, age, education, and co-morbidity of 18 self-reported conditions. Data from the North Denmark Health Profile 2010 was used as population reference in the regression analysis (n=23,392).

Results: The unadjusted EQ-5D-3L mean of ME/CFS was 0.47 [0.41-0.53] compared to a population mean of 0.85 [0.84-0.86]. The OLS regression estimated a disutility of -0.29 [-0.21;-0.34] for ME/CFS patients in this study. The characteristics of ME/CFS patients are different from the population with respect to gender, relationship, employment etc.

Conclusion: The EQ-5D-3L-based HRQoL of ME/CFS is significantly lower than the population mean and the lowest of all the compared conditions. The adjusted analysis confirms that poor HRQoL of ME/CFS is distinctly different from and not a proxy of the other included conditions. However, further studies are needed to exclude the possible selection bias of the current study.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist. The Danish ME/CFS association has supplied manpower in the survey process as well as printing supplies etc. The collaboration of the authors and the Danish ME/CFS association has not involved any economic transactions in any way between the parties.

Figures

Fig 1
Fig 1. EQ-5D-3L distribution ME/CFS sample.
Fig 2
Fig 2. EQ-5D-3L distribution population sample.
Fig 3
Fig 3. Unadjusted means and medians compared to different conditions.

Similar articles

See all similar articles

Cited by 24 articles

See all "Cited by" articles

References

    1. Komaroff a L, Fagioli LR, Doolittle TH, Gandek B, Gleit M a, Guerriero RT, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med. 1996;101: 281–90. 10.1016/S0002-9343(96)00174-X - DOI - PubMed
    1. Nacul LC, Lacerda EM, Campion P, Pheby D, Drachler MDL, Leite JC, et al. The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers. BMC Public Health. BioMed Central Ltd; 2011;11: 402 10.1186/1471-2458-11-402 - DOI - PMC - PubMed
    1. National Institute of Clinical Excellence (NICE). Chronic fatigue syndrome / myalgic encephalomyelitis (or encephalopathy): diagnosis and management of chronic fatigue syndrome / myalgic encephalomyelitis (or encephalopathy) in adults and children [Internet]. 2007. Available: http://guidance.nice.org.uk/CG53/Guidance/pdf/English
    1. Baker R, Shaw EJ. Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance. BMJ. 2007;335: 446–8. 10.1136/bmj.39302.509005.AE - DOI - PMC - PubMed
    1. Avellaneda Fernández A, Pérez Martín A, Izquierdo Martínez M, Arruti Bustillo M, Barbado Hernández FJ, de la Cruz Labrado J, et al. Chronic fatigue syndrome: aetiology, diagnosis and treatment. BMC Psychiatry. 2009;9 Suppl 1: S1 10.1186/1471-244X-9-S1-S1 - DOI - PMC - PubMed

Grant support

The authors received no specific funding for this work.
Feedback